nodes	percent_of_prediction	percent_of_DWPC	metapath
Capreomycin—Leukopenia—Exemestane—breast cancer	0.00445	0.00445	CcSEcCtD
Capreomycin—Hypocalcaemia—Paclitaxel—breast cancer	0.00435	0.00435	CcSEcCtD
Capreomycin—Body temperature increased—Carboplatin—breast cancer	0.00426	0.00426	CcSEcCtD
Capreomycin—Leukopenia—Ixabepilone—breast cancer	0.0042	0.0042	CcSEcCtD
Capreomycin—Hearing impaired—Paclitaxel—breast cancer	0.00418	0.00418	CcSEcCtD
Capreomycin—Urine abnormality—Epirubicin—breast cancer	0.00411	0.00411	CcSEcCtD
Capreomycin—Pain—Fulvestrant—breast cancer	0.004	0.004	CcSEcCtD
Capreomycin—Thrombocytopenia—Exemestane—breast cancer	0.00397	0.00397	CcSEcCtD
Capreomycin—Vertigo—Letrozole—breast cancer	0.00397	0.00397	CcSEcCtD
Capreomycin—Leukopenia—Anastrozole—breast cancer	0.00396	0.00396	CcSEcCtD
Capreomycin—Leukopenia—Letrozole—breast cancer	0.00396	0.00396	CcSEcCtD
Capreomycin—Pain—Toremifene—breast cancer	0.00394	0.00394	CcSEcCtD
Capreomycin—Urine analysis abnormal—Epirubicin—breast cancer	0.00387	0.00387	CcSEcCtD
Capreomycin—Deafness—Gemcitabine—breast cancer	0.00386	0.00386	CcSEcCtD
Capreomycin—Urine abnormality—Doxorubicin—breast cancer	0.0038	0.0038	CcSEcCtD
Capreomycin—Vertigo—Raloxifene—breast cancer	0.00377	0.00377	CcSEcCtD
Capreomycin—Leukopenia—Idarubicin—breast cancer	0.00375	0.00375	CcSEcCtD
Capreomycin—Thrombocytopenia—Ixabepilone—breast cancer	0.00375	0.00375	CcSEcCtD
Capreomycin—Hypersensitivity—Lapatinib—breast cancer	0.00374	0.00374	CcSEcCtD
Capreomycin—Renal impairment—Irinotecan—breast cancer	0.00372	0.00372	CcSEcCtD
Capreomycin—Urticaria—Fulvestrant—breast cancer	0.00371	0.00371	CcSEcCtD
Capreomycin—Body temperature increased—Fulvestrant—breast cancer	0.00369	0.00369	CcSEcCtD
Capreomycin—Oliguria—Docetaxel—breast cancer	0.00366	0.00366	CcSEcCtD
Capreomycin—Renal failure—Goserelin—breast cancer	0.00363	0.00363	CcSEcCtD
Capreomycin—Renal impairment—Gemcitabine—breast cancer	0.00363	0.00363	CcSEcCtD
Capreomycin—Hypomagnesaemia—Epirubicin—breast cancer	0.00358	0.00358	CcSEcCtD
Capreomycin—Urine analysis abnormal—Doxorubicin—breast cancer	0.00358	0.00358	CcSEcCtD
Capreomycin—Hypocalcaemia—Capecitabine—breast cancer	0.00357	0.00357	CcSEcCtD
Capreomycin—Liver disorder—Methotrexate—breast cancer	0.00357	0.00357	CcSEcCtD
Capreomycin—Hearing impaired—Docetaxel—breast cancer	0.00354	0.00354	CcSEcCtD
Capreomycin—Pain—Exemestane—breast cancer	0.00347	0.00347	CcSEcCtD
Capreomycin—Hypersensitivity—Fulvestrant—breast cancer	0.00344	0.00344	CcSEcCtD
Capreomycin—Hearing impaired—Capecitabine—breast cancer	0.00343	0.00343	CcSEcCtD
Capreomycin—Hepatocellular injury—Docetaxel—breast cancer	0.00337	0.00337	CcSEcCtD
Capreomycin—Thrombocytopenia—Raloxifene—breast cancer	0.00335	0.00335	CcSEcCtD
Capreomycin—Thrombocytopenia—Idarubicin—breast cancer	0.00335	0.00335	CcSEcCtD
Capreomycin—Hypomagnesaemia—Doxorubicin—breast cancer	0.00332	0.00332	CcSEcCtD
Capreomycin—Pain—Ixabepilone—breast cancer	0.00328	0.00328	CcSEcCtD
Capreomycin—Deafness—Paclitaxel—breast cancer	0.00323	0.00323	CcSEcCtD
Capreomycin—Urticaria—Exemestane—breast cancer	0.00323	0.00323	CcSEcCtD
Capreomycin—Hypokalaemia—Mitoxantrone—breast cancer	0.00322	0.00322	CcSEcCtD
Capreomycin—Hypokalaemia—Irinotecan—breast cancer	0.00322	0.00322	CcSEcCtD
Capreomycin—Body temperature increased—Exemestane—breast cancer	0.00321	0.00321	CcSEcCtD
Capreomycin—Rash—Lapatinib—breast cancer	0.0032	0.0032	CcSEcCtD
Capreomycin—Dermatitis—Lapatinib—breast cancer	0.0032	0.0032	CcSEcCtD
Capreomycin—Hypokalaemia—Gemcitabine—breast cancer	0.00314	0.00314	CcSEcCtD
Capreomycin—Renal failure—Thiotepa—breast cancer	0.00311	0.00311	CcSEcCtD
Capreomycin—Pain—Letrozole—breast cancer	0.00308	0.00308	CcSEcCtD
Capreomycin—Pain—Anastrozole—breast cancer	0.00308	0.00308	CcSEcCtD
Capreomycin—Abscess—Methotrexate—breast cancer	0.00307	0.00307	CcSEcCtD
Capreomycin—Leukopenia—Chlorambucil—breast cancer	0.00304	0.00304	CcSEcCtD
Capreomycin—Renal impairment—Paclitaxel—breast cancer	0.00304	0.00304	CcSEcCtD
Capreomycin—Body temperature increased—Ixabepilone—breast cancer	0.00303	0.00303	CcSEcCtD
Capreomycin—Hypersensitivity—Exemestane—breast cancer	0.00299	0.00299	CcSEcCtD
Capreomycin—Rash—Fulvestrant—breast cancer	0.00295	0.00295	CcSEcCtD
Capreomycin—Dermatitis—Fulvestrant—breast cancer	0.00294	0.00294	CcSEcCtD
Capreomycin—Pain—Raloxifene—breast cancer	0.00293	0.00293	CcSEcCtD
Capreomycin—Rash—Toremifene—breast cancer	0.00291	0.00291	CcSEcCtD
Capreomycin—Dermatitis—Toremifene—breast cancer	0.00291	0.00291	CcSEcCtD
Capreomycin—Eosinophilia—Fluorouracil—breast cancer	0.0029	0.0029	CcSEcCtD
Capreomycin—Abscess—Epirubicin—breast cancer	0.00288	0.00288	CcSEcCtD
Capreomycin—Urticaria—Letrozole—breast cancer	0.00287	0.00287	CcSEcCtD
Capreomycin—Urticaria—Anastrozole—breast cancer	0.00287	0.00287	CcSEcCtD
Capreomycin—Body temperature increased—Letrozole—breast cancer	0.00285	0.00285	CcSEcCtD
Capreomycin—Body temperature increased—Anastrozole—breast cancer	0.00285	0.00285	CcSEcCtD
Capreomycin—Hypersensitivity—Ixabepilone—breast cancer	0.00282	0.00282	CcSEcCtD
Capreomycin—Vertigo—Vinblastine—breast cancer	0.0028	0.0028	CcSEcCtD
Capreomycin—Leukopenia—Vinblastine—breast cancer	0.00279	0.00279	CcSEcCtD
Capreomycin—Deafness—Docetaxel—breast cancer	0.00274	0.00274	CcSEcCtD
Capreomycin—Urticaria—Idarubicin—breast cancer	0.00272	0.00272	CcSEcCtD
Capreomycin—Thrombocytopenia—Chlorambucil—breast cancer	0.00271	0.00271	CcSEcCtD
Capreomycin—Leukopenia—Tamoxifen—breast cancer	0.00271	0.00271	CcSEcCtD
Capreomycin—Body temperature increased—Raloxifene—breast cancer	0.00271	0.00271	CcSEcCtD
Capreomycin—Body temperature increased—Idarubicin—breast cancer	0.00271	0.00271	CcSEcCtD
Capreomycin—Renal failure—Irinotecan—breast cancer	0.00268	0.00268	CcSEcCtD
Capreomycin—Renal failure—Mitoxantrone—breast cancer	0.00268	0.00268	CcSEcCtD
Capreomycin—Abscess—Doxorubicin—breast cancer	0.00266	0.00266	CcSEcCtD
Capreomycin—Hypersensitivity—Anastrozole—breast cancer	0.00266	0.00266	CcSEcCtD
Capreomycin—Deafness—Capecitabine—breast cancer	0.00265	0.00265	CcSEcCtD
Capreomycin—Leukopenia—Melphalan—breast cancer	0.00265	0.00265	CcSEcCtD
Capreomycin—Tinnitus—Thiotepa—breast cancer	0.00265	0.00265	CcSEcCtD
Capreomycin—Oliguria—Methotrexate—breast cancer	0.00264	0.00264	CcSEcCtD
Capreomycin—Hypokalaemia—Paclitaxel—breast cancer	0.00263	0.00263	CcSEcCtD
Capreomycin—Renal failure—Gemcitabine—breast cancer	0.00261	0.00261	CcSEcCtD
Capreomycin—Leukopenia—Goserelin—breast cancer	0.00259	0.00259	CcSEcCtD
Capreomycin—Renal impairment—Docetaxel—breast cancer	0.00257	0.00257	CcSEcCtD
Capreomycin—Rash—Exemestane—breast cancer	0.00256	0.00256	CcSEcCtD
Capreomycin—Dermatitis—Exemestane—breast cancer	0.00256	0.00256	CcSEcCtD
Capreomycin—Hypersensitivity—Idarubicin—breast cancer	0.00252	0.00252	CcSEcCtD
Capreomycin—Renal impairment—Capecitabine—breast cancer	0.00249	0.00249	CcSEcCtD
Capreomycin—Thrombocytopenia—Vinblastine—breast cancer	0.00249	0.00249	CcSEcCtD
Capreomycin—Hypocalcaemia—Epirubicin—breast cancer	0.00249	0.00249	CcSEcCtD
Capreomycin—Oliguria—Epirubicin—breast cancer	0.00247	0.00247	CcSEcCtD
Capreomycin—Thrombocytopenia—Tamoxifen—breast cancer	0.00242	0.00242	CcSEcCtD
Capreomycin—Rash—Ixabepilone—breast cancer	0.00242	0.00242	CcSEcCtD
Capreomycin—Dermatitis—Ixabepilone—breast cancer	0.00241	0.00241	CcSEcCtD
Capreomycin—Pain—Chlorambucil—breast cancer	0.00237	0.00237	CcSEcCtD
Capreomycin—Thrombocytopenia—Melphalan—breast cancer	0.00237	0.00237	CcSEcCtD
Capreomycin—Vertigo—Vinorelbine—breast cancer	0.00232	0.00232	CcSEcCtD
Capreomycin—Leukopenia—Vinorelbine—breast cancer	0.00232	0.00232	CcSEcCtD
Capreomycin—Thrombocytopenia—Goserelin—breast cancer	0.00231	0.00231	CcSEcCtD
Capreomycin—Hypocalcaemia—Doxorubicin—breast cancer	0.0023	0.0023	CcSEcCtD
Capreomycin—Oliguria—Doxorubicin—breast cancer	0.00229	0.00229	CcSEcCtD
Capreomycin—Hepatocellular injury—Epirubicin—breast cancer	0.00228	0.00228	CcSEcCtD
Capreomycin—Rash—Letrozole—breast cancer	0.00227	0.00227	CcSEcCtD
Capreomycin—Rash—Anastrozole—breast cancer	0.00227	0.00227	CcSEcCtD
Capreomycin—Dermatitis—Anastrozole—breast cancer	0.00227	0.00227	CcSEcCtD
Capreomycin—Dermatitis—Letrozole—breast cancer	0.00227	0.00227	CcSEcCtD
Capreomycin—Leukopenia—Thiotepa—breast cancer	0.00221	0.00221	CcSEcCtD
Capreomycin—Urticaria—Chlorambucil—breast cancer	0.0022	0.0022	CcSEcCtD
Capreomycin—Body temperature increased—Chlorambucil—breast cancer	0.00219	0.00219	CcSEcCtD
Capreomycin—Renal failure—Paclitaxel—breast cancer	0.00219	0.00219	CcSEcCtD
Capreomycin—Pain—Vinblastine—breast cancer	0.00217	0.00217	CcSEcCtD
Capreomycin—Rash—Idarubicin—breast cancer	0.00216	0.00216	CcSEcCtD
Capreomycin—Rash—Raloxifene—breast cancer	0.00216	0.00216	CcSEcCtD
Capreomycin—Hypokalaemia—Capecitabine—breast cancer	0.00216	0.00216	CcSEcCtD
Capreomycin—Dermatitis—Raloxifene—breast cancer	0.00216	0.00216	CcSEcCtD
Capreomycin—Dermatitis—Idarubicin—breast cancer	0.00216	0.00216	CcSEcCtD
Capreomycin—Pain—Tamoxifen—breast cancer	0.00211	0.00211	CcSEcCtD
Capreomycin—Hepatocellular injury—Doxorubicin—breast cancer	0.00211	0.00211	CcSEcCtD
Capreomycin—Thrombocytopenia—Vinorelbine—breast cancer	0.00207	0.00207	CcSEcCtD
Capreomycin—Pain—Melphalan—breast cancer	0.00207	0.00207	CcSEcCtD
Capreomycin—Hypersensitivity—Chlorambucil—breast cancer	0.00204	0.00204	CcSEcCtD
Capreomycin—Pain—Goserelin—breast cancer	0.00202	0.00202	CcSEcCtD
Capreomycin—Thrombocytopenia—Thiotepa—breast cancer	0.00197	0.00197	CcSEcCtD
Capreomycin—Urticaria—Tamoxifen—breast cancer	0.00196	0.00196	CcSEcCtD
Capreomycin—Urticaria—Melphalan—breast cancer	0.00192	0.00192	CcSEcCtD
Capreomycin—Vertigo—Irinotecan—breast cancer	0.00192	0.00192	CcSEcCtD
Capreomycin—Leukopenia—Mitoxantrone—breast cancer	0.00191	0.00191	CcSEcCtD
Capreomycin—Leukopenia—Irinotecan—breast cancer	0.00191	0.00191	CcSEcCtD
Capreomycin—Urticaria—Goserelin—breast cancer	0.00187	0.00187	CcSEcCtD
Capreomycin—Hypersensitivity—Vinblastine—breast cancer	0.00187	0.00187	CcSEcCtD
Capreomycin—Tinnitus—Paclitaxel—breast cancer	0.00186	0.00186	CcSEcCtD
Capreomycin—Body temperature increased—Goserelin—breast cancer	0.00186	0.00186	CcSEcCtD
Capreomycin—Leukopenia—Gemcitabine—breast cancer	0.00186	0.00186	CcSEcCtD
Capreomycin—Renal failure—Docetaxel—breast cancer	0.00186	0.00186	CcSEcCtD
Capreomycin—Leukopenia—Fluorouracil—breast cancer	0.00183	0.00183	CcSEcCtD
Capreomycin—Hypersensitivity—Tamoxifen—breast cancer	0.00182	0.00182	CcSEcCtD
Capreomycin—Pain—Vinorelbine—breast cancer	0.00181	0.00181	CcSEcCtD
Capreomycin—Renal failure—Capecitabine—breast cancer	0.0018	0.0018	CcSEcCtD
Capreomycin—Hypersensitivity—Melphalan—breast cancer	0.00178	0.00178	CcSEcCtD
Capreomycin—Hypersensitivity—Goserelin—breast cancer	0.00174	0.00174	CcSEcCtD
Capreomycin—Renal impairment—Epirubicin—breast cancer	0.00174	0.00174	CcSEcCtD
Capreomycin—Pain—Thiotepa—breast cancer	0.00172	0.00172	CcSEcCtD
Capreomycin—Thrombocytopenia—Mitoxantrone—breast cancer	0.00171	0.00171	CcSEcCtD
Capreomycin—Thrombocytopenia—Irinotecan—breast cancer	0.00171	0.00171	CcSEcCtD
Capreomycin—Urticaria—Vinorelbine—breast cancer	0.00168	0.00168	CcSEcCtD
Capreomycin—Body temperature increased—Vinorelbine—breast cancer	0.00167	0.00167	CcSEcCtD
Capreomycin—Thrombocytopenia—Gemcitabine—breast cancer	0.00166	0.00166	CcSEcCtD
Capreomycin—Thrombocytopenia—Fluorouracil—breast cancer	0.00163	0.00163	CcSEcCtD
Capreomycin—Renal impairment—Doxorubicin—breast cancer	0.00161	0.00161	CcSEcCtD
Capreomycin—Urticaria—Thiotepa—breast cancer	0.0016	0.0016	CcSEcCtD
Capreomycin—Body temperature increased—Thiotepa—breast cancer	0.00159	0.00159	CcSEcCtD
Capreomycin—Vertigo—Paclitaxel—breast cancer	0.00156	0.00156	CcSEcCtD
Capreomycin—Leukopenia—Paclitaxel—breast cancer	0.00156	0.00156	CcSEcCtD
Capreomycin—Rash—Tamoxifen—breast cancer	0.00156	0.00156	CcSEcCtD
Capreomycin—Hypersensitivity—Vinorelbine—breast cancer	0.00156	0.00156	CcSEcCtD
Capreomycin—Dermatitis—Tamoxifen—breast cancer	0.00155	0.00155	CcSEcCtD
Capreomycin—Tinnitus—Capecitabine—breast cancer	0.00153	0.00153	CcSEcCtD
Capreomycin—Rash—Melphalan—breast cancer	0.00152	0.00152	CcSEcCtD
Capreomycin—Dermatitis—Melphalan—breast cancer	0.00152	0.00152	CcSEcCtD
Capreomycin—Eosinophilia—Methotrexate—breast cancer	0.00151	0.00151	CcSEcCtD
Capreomycin—Hypokalaemia—Epirubicin—breast cancer	0.0015	0.0015	CcSEcCtD
Capreomycin—Pain—Mitoxantrone—breast cancer	0.00149	0.00149	CcSEcCtD
Capreomycin—Pain—Irinotecan—breast cancer	0.00149	0.00149	CcSEcCtD
Capreomycin—Rash—Goserelin—breast cancer	0.00149	0.00149	CcSEcCtD
Capreomycin—Hypersensitivity—Thiotepa—breast cancer	0.00149	0.00149	CcSEcCtD
Capreomycin—Dermatitis—Goserelin—breast cancer	0.00149	0.00149	CcSEcCtD
Capreomycin—Pain—Gemcitabine—breast cancer	0.00145	0.00145	CcSEcCtD
Capreomycin—Pain—Fluorouracil—breast cancer	0.00143	0.00143	CcSEcCtD
Capreomycin—Eosinophilia—Epirubicin—breast cancer	0.00141	0.00141	CcSEcCtD
Capreomycin—Hypokalaemia—Doxorubicin—breast cancer	0.00139	0.00139	CcSEcCtD
Capreomycin—Thrombocytopenia—Paclitaxel—breast cancer	0.00139	0.00139	CcSEcCtD
Capreomycin—Urticaria—Mitoxantrone—breast cancer	0.00138	0.00138	CcSEcCtD
Capreomycin—Body temperature increased—Mitoxantrone—breast cancer	0.00138	0.00138	CcSEcCtD
Capreomycin—Body temperature increased—Irinotecan—breast cancer	0.00138	0.00138	CcSEcCtD
Capreomycin—Body temperature increased—Gemcitabine—breast cancer	0.00134	0.00134	CcSEcCtD
Capreomycin—Renal failure—Methotrexate—breast cancer	0.00134	0.00134	CcSEcCtD
Capreomycin—Rash—Vinorelbine—breast cancer	0.00133	0.00133	CcSEcCtD
Capreomycin—Dermatitis—Vinorelbine—breast cancer	0.00133	0.00133	CcSEcCtD
Capreomycin—Urticaria—Fluorouracil—breast cancer	0.00133	0.00133	CcSEcCtD
Capreomycin—Leukopenia—Docetaxel—breast cancer	0.00132	0.00132	CcSEcCtD
Capreomycin—Body temperature increased—Fluorouracil—breast cancer	0.00132	0.00132	CcSEcCtD
Capreomycin—Eosinophilia—Doxorubicin—breast cancer	0.00131	0.00131	CcSEcCtD
Capreomycin—Vertigo—Capecitabine—breast cancer	0.00128	0.00128	CcSEcCtD
Capreomycin—Hypersensitivity—Mitoxantrone—breast cancer	0.00128	0.00128	CcSEcCtD
Capreomycin—Hypersensitivity—Irinotecan—breast cancer	0.00128	0.00128	CcSEcCtD
Capreomycin—Leukopenia—Capecitabine—breast cancer	0.00128	0.00128	CcSEcCtD
Capreomycin—Rash—Thiotepa—breast cancer	0.00127	0.00127	CcSEcCtD
Capreomycin—Dermatitis—Thiotepa—breast cancer	0.00127	0.00127	CcSEcCtD
Capreomycin—Renal failure—Epirubicin—breast cancer	0.00125	0.00125	CcSEcCtD
Capreomycin—Hypersensitivity—Fluorouracil—breast cancer	0.00123	0.00123	CcSEcCtD
Capreomycin—Pain—Paclitaxel—breast cancer	0.00121	0.00121	CcSEcCtD
Capreomycin—Thrombocytopenia—Docetaxel—breast cancer	0.00118	0.00118	CcSEcCtD
Capreomycin—Renal failure—Doxorubicin—breast cancer	0.00116	0.00116	CcSEcCtD
Capreomycin—Thrombocytopenia—Capecitabine—breast cancer	0.00114	0.00114	CcSEcCtD
Capreomycin—Tinnitus—Methotrexate—breast cancer	0.00114	0.00114	CcSEcCtD
Capreomycin—Urticaria—Paclitaxel—breast cancer	0.00113	0.00113	CcSEcCtD
Capreomycin—Body temperature increased—Paclitaxel—breast cancer	0.00112	0.00112	CcSEcCtD
Capreomycin—Rash—Irinotecan—breast cancer	0.0011	0.0011	CcSEcCtD
Capreomycin—Rash—Mitoxantrone—breast cancer	0.0011	0.0011	CcSEcCtD
Capreomycin—Dermatitis—Irinotecan—breast cancer	0.0011	0.0011	CcSEcCtD
Capreomycin—Dermatitis—Mitoxantrone—breast cancer	0.0011	0.0011	CcSEcCtD
Capreomycin—Rash—Gemcitabine—breast cancer	0.00107	0.00107	CcSEcCtD
Capreomycin—Dermatitis—Gemcitabine—breast cancer	0.00107	0.00107	CcSEcCtD
Capreomycin—Tinnitus—Epirubicin—breast cancer	0.00107	0.00107	CcSEcCtD
Capreomycin—Rash—Fluorouracil—breast cancer	0.00105	0.00105	CcSEcCtD
Capreomycin—Dermatitis—Fluorouracil—breast cancer	0.00105	0.00105	CcSEcCtD
Capreomycin—Hypersensitivity—Paclitaxel—breast cancer	0.00105	0.00105	CcSEcCtD
Capreomycin—Pain—Docetaxel—breast cancer	0.00103	0.00103	CcSEcCtD
Capreomycin—Pain—Capecitabine—breast cancer	0.000997	0.000997	CcSEcCtD
Capreomycin—Tinnitus—Doxorubicin—breast cancer	0.000986	0.000986	CcSEcCtD
Capreomycin—Vertigo—Methotrexate—breast cancer	0.000955	0.000955	CcSEcCtD
Capreomycin—Body temperature increased—Docetaxel—breast cancer	0.000952	0.000952	CcSEcCtD
Capreomycin—Leukopenia—Methotrexate—breast cancer	0.000952	0.000952	CcSEcCtD
Capreomycin—Urticaria—Capecitabine—breast cancer	0.000926	0.000926	CcSEcCtD
Capreomycin—Body temperature increased—Capecitabine—breast cancer	0.000921	0.000921	CcSEcCtD
Capreomycin—Rash—Paclitaxel—breast cancer	0.000896	0.000896	CcSEcCtD
Capreomycin—Dermatitis—Paclitaxel—breast cancer	0.000895	0.000895	CcSEcCtD
Capreomycin—Vertigo—Epirubicin—breast cancer	0.000894	0.000894	CcSEcCtD
Capreomycin—Leukopenia—Epirubicin—breast cancer	0.000891	0.000891	CcSEcCtD
Capreomycin—Hypersensitivity—Docetaxel—breast cancer	0.000887	0.000887	CcSEcCtD
Capreomycin—Hypersensitivity—Capecitabine—breast cancer	0.000859	0.000859	CcSEcCtD
Capreomycin—Thrombocytopenia—Methotrexate—breast cancer	0.00085	0.00085	CcSEcCtD
Capreomycin—Vertigo—Doxorubicin—breast cancer	0.000827	0.000827	CcSEcCtD
Capreomycin—Leukopenia—Doxorubicin—breast cancer	0.000824	0.000824	CcSEcCtD
Capreomycin—Thrombocytopenia—Epirubicin—breast cancer	0.000795	0.000795	CcSEcCtD
Capreomycin—Rash—Docetaxel—breast cancer	0.000759	0.000759	CcSEcCtD
Capreomycin—Dermatitis—Docetaxel—breast cancer	0.000758	0.000758	CcSEcCtD
Capreomycin—Pain—Methotrexate—breast cancer	0.000742	0.000742	CcSEcCtD
Capreomycin—Thrombocytopenia—Doxorubicin—breast cancer	0.000736	0.000736	CcSEcCtD
Capreomycin—Rash—Capecitabine—breast cancer	0.000735	0.000735	CcSEcCtD
Capreomycin—Dermatitis—Capecitabine—breast cancer	0.000734	0.000734	CcSEcCtD
Capreomycin—Pain—Epirubicin—breast cancer	0.000694	0.000694	CcSEcCtD
Capreomycin—Urticaria—Methotrexate—breast cancer	0.000689	0.000689	CcSEcCtD
Capreomycin—Body temperature increased—Methotrexate—breast cancer	0.000686	0.000686	CcSEcCtD
Capreomycin—Urticaria—Epirubicin—breast cancer	0.000645	0.000645	CcSEcCtD
Capreomycin—Pain—Doxorubicin—breast cancer	0.000642	0.000642	CcSEcCtD
Capreomycin—Body temperature increased—Epirubicin—breast cancer	0.000642	0.000642	CcSEcCtD
Capreomycin—Hypersensitivity—Methotrexate—breast cancer	0.000639	0.000639	CcSEcCtD
Capreomycin—Hypersensitivity—Epirubicin—breast cancer	0.000598	0.000598	CcSEcCtD
Capreomycin—Urticaria—Doxorubicin—breast cancer	0.000597	0.000597	CcSEcCtD
Capreomycin—Body temperature increased—Doxorubicin—breast cancer	0.000594	0.000594	CcSEcCtD
Capreomycin—Hypersensitivity—Doxorubicin—breast cancer	0.000554	0.000554	CcSEcCtD
Capreomycin—Rash—Methotrexate—breast cancer	0.000547	0.000547	CcSEcCtD
Capreomycin—Dermatitis—Methotrexate—breast cancer	0.000547	0.000547	CcSEcCtD
Capreomycin—Rash—Epirubicin—breast cancer	0.000512	0.000512	CcSEcCtD
Capreomycin—Dermatitis—Epirubicin—breast cancer	0.000512	0.000512	CcSEcCtD
Capreomycin—Rash—Doxorubicin—breast cancer	0.000474	0.000474	CcSEcCtD
Capreomycin—Dermatitis—Doxorubicin—breast cancer	0.000473	0.000473	CcSEcCtD
